Author name: comtex

Securities Class Action Lawsuit Filed Against XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP (XIFR) – Levi & Korsinsky Represents Shareholders

NEW YORK, NY / ACCESS Newswire / July 25, 2025 / If you suffered a loss on your XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP (NYSE:XIFR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/xplr-infrastructure-lp-f-k-a-nextera-energy-partners-lp-lawsuit-submission-form?prid=158257&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq. […]

Class Action Lawsuit Alert: Levi & Korsinsky Reminds Neogen Corporation (NEOG) Investors of September 16, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / July 25, 2025 / If you suffered a loss on your Neogen Corporation (NASDAQ:NEOG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neogen-corporation-lawsuit-submission-form?prid=158256&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

REPL ALERT: Ongoing Investigation Into Replimune Group, Inc. – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / July 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Replimune Group, Inc. ("Replimune Group, Inc.") (NASDAQ:REPL) concerning possible violations of federal securities laws. On July 22, 2025, Replimune announced that it received a Complete Response Letter from the FDA rejecting its

America Must Win the Energy War: CrowdPoint Unveils Strategic Blueprint to Reinvent the U.S. Power Grid

America Must Win the Energy War: CrowdPoint Unveils Strategic Blueprint to Reinvent the U.S. Power Grid With America's aging power grid teetering on the brink of collapse, CrowdPoint Technologies President Nadab U. Akhtar has issued a powerful call to arms: it's time to stop maintaining the grid–and start commanding it. GlobeNewswire July 25, 2025 Austin,

CNC INVESTOR NEWS: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Centene Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CNC

NEW YORK, NY / ACCESS Newswire / July 25, 2025 / WHY: New York, N.Y., July 25, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Centene Corporation (NYSE:CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (the "Class Period"), of the important September 8, 2025

Western Asset Management Company, LLC Mutual Fund Investors Have Opportunity to Lead Western Asset Management Company Securities Fraud Lawsuit

https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the “Western Asset US Core Bond Fund” mutual fund classes – Class I (ticker: “WATFX”), Class A (ticker: “WABAX”), Class C (ticker: “WABCX”), Class FI (ticker: “WAPIX”), Class IS (ticker: “WACSX”),

ChoiceCash expands online auto equity loans to Hawaii (Oahu)

On July 10th 2025, ChoiceCash increased the coverage of its online auto equity loan product to Hawaii (Oahu). Effective immediately, Oahu residents can apply for a ChoiceCash loan online or by calling 855-422-7402, Monday – Friday 7:00 a.m. to 5:00 p.m. PT; and Saturday 7:00 a.m. to 4:00 p.m. PT. Launched more than 5 years

Securities Lawsuit Alert: Capricor Therapeutics, Inc. (CAPR) Investors – Contact Levi & Korsinsky Before September 15, 2025

NEW YORK, NY / ACCESS Newswire / July 25, 2025 / If you suffered a loss on your Capricor Therapeutics, Inc. (NASDAQ:CAPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/capricor-therapeutics-inc-lawsuit-submission-form-2?prid=158255&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Securities Class Action Lawsuit Filed Against Sarepta Therapeutics, Inc. (SRPT) – Levi & Korsinsky Represents Shareholders

NEW YORK, NY / ACCESS Newswire / July 25, 2025 / If you suffered a loss on your Sarepta Therapeutics, Inc. (NASDAQ:SRPT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sarepta-lawsuit-submission-form?prid=158254&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Scroll to Top